Document is current
Any future updates will be listed below
-
Authors
Namiki, Takao https://orcid.org/0000-0003-1047-7999
Takayama, Shin
Arita, Ryutaro
Ishii, Tadashi
Kainuma, Mosaburo
Makino, Toshiaki
Mimura, Masaru
Yoshino, Tetsuhiro
Nogami, Tatsuya
Arai, Makoto
Sato, Juichi
Tanaka, Koichiro
Nakae, Hajime
Igari, Hidetoshi
Ozawa, Yoshihito
Shiko, Yuki
Kawasaki, Yohei
Nezu, Masahiko
Ito, Takashi
-
Funding
Funding for this research was provided by:
The Japan Society of Oriental Medicine
- License Information
-
More Information
Article History
Received: 15 November 2020
Accepted: 30 November 2020
First Online: 6 January 2021
Ethics approval and consent to participate
: Approved by the Ministry of Health, Labour and Welfare (MHLW) Certified Clinical Research Review Board, Chiba University Hospital, Japan, on August 19, 2020 with certificate No. CRB0040-20. The authors certify that this trial has received ethical approval from the appropriate ethical committee as described above.Before inclusion in the study, conscious patients must be informed of the purpose of the study and of the clinical procedures required by the protocol. The investigators in each hospital will explain the purpose, risks and benefits associated with study participation. In addition, patients will be informed of their right to withdraw from the study at any time without explanation and without losing the right to future medical care.All participants who recover sufficiently will be given the opportunity to provide their informed consent for ongoing study participation and for the use of data collected for the study. Every patient is free to leave the study protocol at any stage of the study, may withdraw his or her consent, and may request that all of his or her data be eliminated from the database.
: Not applicable.
: The authors have no competing interests to declare.
